Quanterix Corp
QTRX5.430USD
-0.150-2.69%
Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min
211.08MCap. mercado
PérdidaP/E TTM
Más Datos de Quanterix Corp Compañía
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.
Información de la empresa
Símbolo de cotizaciónQTRX
Nombre de la empresaQuanterix Corp
Fecha de salida a bolsaDec 07, 2017
Director ejecutivoDr. Masoud Toloue, Ph.D.
Número de empleados471
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 07
Dirección900 Middlesex Turnpike
CiudadBILLERICA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01821
Teléfono16173019400
Sitio Webhttps://www.quanterix.com/
Símbolo de cotizaciónQTRX
Fecha de salida a bolsaDec 07, 2017
Director ejecutivoDr. Masoud Toloue, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
288.86K
-0.43%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
133.06K
+5.49%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
15.30K
+34.46%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
4.19K
--
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Independent Director
Independent Director
3.96K
-79.63%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
2.94K
--
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Paul M. Meister
Mr. Paul M. Meister
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
288.86K
-0.43%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
133.06K
+5.49%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
--
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
15.30K
+34.46%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
4.19K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
Por regiónUSD
Nombre
Ganancia
Proporción
North America
19.38M
64.01%
EMEA
6.63M
21.92%
Asia Pacific
4.26M
14.07%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Portolan Capital Management, L.L.C.
7.82%
Columbia Threadneedle Investments (UK)
6.73%
BlackRock Institutional Trust Company, N.A.
5.70%
The Vanguard Group, Inc.
5.44%
Kent Lake PR LLC
4.50%
Otro
69.81%
Accionistas
Accionistas
Proporción
Portolan Capital Management, L.L.C.
7.82%
Columbia Threadneedle Investments (UK)
6.73%
BlackRock Institutional Trust Company, N.A.
5.70%
The Vanguard Group, Inc.
5.44%
Kent Lake PR LLC
4.50%
Otro
69.81%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
34.26%
Investment Advisor
20.99%
Hedge Fund
13.18%
Individual Investor
6.47%
Research Firm
3.94%
Pension Fund
0.67%
Bank and Trust
0.27%
Family Office
0.13%
Venture Capital
0.12%
Otro
19.97%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
391
36.46M
81.18%
-12.95M
2025Q1
401
40.45M
104.19%
-6.42M
2024Q4
388
38.02M
98.63%
-6.28M
2024Q3
386
36.47M
95.03%
-5.94M
2024Q2
394
35.66M
93.20%
-9.57M
2024Q1
395
35.56M
93.43%
-9.17M
2023Q4
388
34.77M
91.99%
-10.35M
2023Q3
382
36.53M
97.35%
-9.84M
2023Q2
388
36.74M
98.24%
-9.95M
2023Q1
389
37.25M
100.03%
-8.36M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Portolan Capital Management, L.L.C.
2.96M
7.63%
+375.57K
+14.51%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
3.00M
7.72%
+237.57K
+8.60%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.68M
6.91%
-89.03K
-3.21%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
6.5%
+316.41K
+14.32%
Mar 31, 2025
Kent Lake PR LLC
2.92M
7.53%
+279.82K
+10.58%
Mar 31, 2025
Walt (David R)
1.86M
4.79%
+370.00K
+24.84%
Jun 13, 2025
Invenomic Capital Management LP
902.04K
2.32%
+546.67K
+153.83%
Mar 31, 2025
William Blair Investment Management, LLC
1.11M
2.85%
+43.96K
+4.14%
Mar 31, 2025
Columbia Threadneedle Investments (US)
716.23K
1.84%
+271.74K
+61.14%
Mar 31, 2025
Easterly Investment Partners LLC
1.33M
3.41%
+370.63K
+38.81%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
